The majority of patients experience significant weight regain if treatment with GLP-1 medications stops, and it is unclear if there will be a sustainable, long-term access to GLP-1 treatment for obesity for Medicare beneficiaries. Nielsen says she anticipates demand for the GLP-1 Bridge program will be high, making it important to see your healthcare provider for an evaluation now
Constipation: While less common than diarrhea, some patients report constipation as a side effect
Maybe like your mom or your aunt that's going through menopause or like a friend that just had a baby and is experiencing that postpartum hair shedding
If you are managing weight, metabolic health, or other conditions alongside acetaminophen use, discussing your medication history and detoxification profile with your provider supports a more personalized approach
Additionally, a large pipeline of entero-pancreatic hormone-based pharmacotherapies is under development, with the aim to enhance and/or compliment the efficacy and mechanisms of action of GLP-1 RA (Table 1, Fig
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: A United States multicentre study